Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

Sponsor
Tianjin Eye Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05192824
Collaborator
(none)
200
1
5
48.7
4.1

Study Details

Study Description

Brief Summary

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

Condition or Disease Intervention/Treatment Phase
  • Device: Orthokeratology lens
N/A

Detailed Description

This study was aimed to evaluate the effects of different Orthokeratology on myopia control and visual quality. The different optical zone of Orthokeratology lens was divided into 4 groups, ranged from 5.5 mm to 6 mm. And the control group subjects with the single glasses was included. The effectiveness of Orthokeratology was measured by axial length progression. The visual quality of subjects was evaluated by a questionnaire, contrast sensitivity and wavefront aberration.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality
Actual Study Start Date :
Dec 10, 2021
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Single-vision glasses

Subjects wearing single-vision glasses CR-39

Experimental: Orthokeratology lenses group 1

Subjects wearing orthokeratology lenses of 5mm optical zone.

Device: Orthokeratology lens
The intervention was according to the design of different optical zone and peripheral reverse curve
Other Names:
  • Ortho-K
  • Experimental: Orthokeratology lenses group 2

    Subjects wearing orthokeratology lenses of 5.5mm optical zone.

    Device: Orthokeratology lens
    The intervention was according to the design of different optical zone and peripheral reverse curve
    Other Names:
  • Ortho-K
  • Experimental: Orthokeratology lenses group 3

    Subjects wearing orthokeratology lenses of 6mm optical zone.

    Device: Orthokeratology lens
    The intervention was according to the design of different optical zone and peripheral reverse curve
    Other Names:
  • Ortho-K
  • Experimental: Orthokeratology lenses group 4

    Subjects wearing orthokeratology lenses of 6mm optical zone and the increased height of peripheral reverse curve.

    Device: Orthokeratology lens
    The intervention was according to the design of different optical zone and peripheral reverse curve
    Other Names:
  • Ortho-K
  • Outcome Measures

    Primary Outcome Measures

    1. Changes in axial length in 2 years [Every 6 months for a period 2 years]

      The axial length was measured by AL-scan

    2. Changes in Cycloplegic subjective refraction in 2 years [Every 6 months for a period 2 years]

      The cycloplegic subjective refraction was evaluated by optometrist

    Secondary Outcome Measures

    1. Change in visual questionnaire as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      The symptoms score measured by a visual questionnaire, each symptom was evaluated on a scale of 0 to 10.

    2. Change in High-order aberrations (HOAs) in microns as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      Ocular aberration measured by Zeiss i. Profiler Plus aberrometer

    3. Change in contrast sensitivity as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      Contrast sensitivity measured by Stereo optical 6500

    4. Change in choroidal thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      choroidal thickness captured by Optical Coherent Tomographer (OCT) and measured using a customized software

    5. Change in Corneal epithelial thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      Corneal epithelial thickness captured by Optical Coherent Tomographer (OCT) customized software

    6. Change in corneal biomechanics parameters (SSI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      Corneal response parameters(SSI) was evaluated by Corvis ST.

    7. Change in peripheral refraction as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      Peripheral refraction measured by multispectral refraction topography

    8. Change in corneal surface regularity index (SRI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      The corneal surface regularity index (SRI) was measured by Corneal Topography.

    9. Change in corneal surface asymmetry index (SAI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months) [baseline, postoperative 6 months, 12 months, 18 months and 24 months]

      The corneal surface asymmetry index (SAI) was measured by Corneal Topography.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 13 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Myopia: between -1.00D and 4.00D in both eyes

    • Astigmatism: <1.5D for with-the-rule astigmatism, <1.00D for the against-the-rule astigmatism

    • Visual acuity: the best corrected vision acuity(BCVA)≥20/20 in both eyes

    • Subjects that volunteer to participate in the clinical trial and sign informed consent

    Exclusion Criteria:
    • Contraindications of wearing Ortho-K.

    • Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.

    • Any type of strabismus or amblyopia

    • Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)

    • Ocular conditions which might affect the refractive error (for example, cataract, ptosis)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tianjin Eye Hospital Tianjin Tianjin China 300020

    Sponsors and Collaborators

    • Tianjin Eye Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Shuxian zhang, Director, Tianjin Eye Hospital
    ClinicalTrials.gov Identifier:
    NCT05192824
    Other Study ID Numbers:
    • TianjinEH-Orthokeratology lens
    First Posted:
    Jan 14, 2022
    Last Update Posted:
    Jan 14, 2022
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 14, 2022